Overview
Takefumi Katsuragi practices practicing medicine in Kitakyushu, Japan.
Their clinical expertise encompasses Adult T-Cell Leukemia, Breast Enlargement In Males, and Leukemia.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takefumi Katsuragi
Is Takefumi Katsuragi a top-rated expert for Adult T-Cell Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Takefumi Katsuragi is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takefumi Katsuragi participate in research or clinical trials?
Yes. Takefumi Katsuragi has published 8 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of Takefumi Katsuragi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult T-Cell LeukemiaKatsuragi isExperienced. Learn about Adult T-Cell Leukemia.
- Breast Enlargement In MalesKatsuragi isExperienced. Learn about Breast Enlargement In Males.
- LeukemiaKatsuragi isExperienced. Learn about Leukemia.